Abstract

Single nucleotide polymorphisms (SNPs) and genes associated with susceptibility to hepatitis B virus (HBV) infection that have been identified by genome-wide association studies explain only a limited portion of the known heritability, indicating more genetic variants remain to be discovered. In this study, we adopted a new research strategy to identify more susceptibility genes and variants for HBV infection. We first performed genetic association analysis of 300 sib-pairs and 3,087 case-control samples, which revealed that 36 SNPs located in 31 genes showed nominal associations with HBV infection in both samples. Of these genes, we selected SEC24D for further molecular analysis according to the following two main lines of evidence. First, a time course analysis of the expression profiles from HBV-infected primary human hepatocytes (PHH) demonstrated that SEC24D expression increased markedly as time passed after HBV infection (P = 4.0 × 10−4). Second, SNP rs76459466 in SEC24D was adversely associated with HBV risk (ORmeta = 0.82; Pmeta = 0.002), which again indicated that SEC24D represents a novel susceptibility gene for HBV infection. Moreover, SEC24D appeared to be protective against HBV infection in vitro. Consistently, we found that SEC24D expression was significantly enhanced in non-infected liver tissues (P = 0.002). We conclude that SEC24D is a novel candidate gene linked to susceptibility to HBV infection.

Highlights

  • Hepatitis B virus (HBV) infection is a serious global health issue and shows marked geographic diversity

  • We used sibling transmission/disequilibrium test (sTDT) analysis of WES data to identify single nucleotide polymorphisms (SNPs) that were significant in 300 Chronic HBV infection (CHBVI) compared with 300 unaffected siblings

  • To narrow down the candidates for the causative genes, we performed time course analysis to investigate the expression of genes that displayed significant time-related changes induced by hepatitis B virus (HBV)

Read more

Summary

Introduction

Hepatitis B virus (HBV) infection is a serious global health issue and shows marked geographic diversity. Despite the availability of a potent HBV vaccine and effective antiviral drugs for two decades, hepatitis B maintains at high prevalence worldwide, with more than 240 million people infected[3]. Chronic HBV infection (CHBVI) and viral clearance are influenced by multiple genetic and environmental factors, including viral and host factors[5,6,7]. Twin and segregation studies indicate that host genetic components strongly influence the outcome of HBV infection[8]. Genome-wide association study (GWAS) has been used to identify genetic variants for numerous complex human diseases such as HBV infection and clearance. To further elucidate disease-predisposing genes for HBV infection, we employed an integrative functional genomics strategy, which can be summarized briefly as follows. Through a series of in vitro experiments, we found SEC24D to be an antiviral gene for HBV infection

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call